Clinical Trials
24 trialsNCT04996875 2026-05-05
APEX
Cogent Biosciences, Inc.
Phase 2 Recruiting
NCT07144345 2026-04-22
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
Sun Pharmaceutical Industries Limited
Phase 3 Recruiting
NCT07144852 2026-04-22
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
Sun Pharmaceutical Industries Limited
Phase 3 Recruiting
NCT01909453 2026-02-27
COLUMBUS
Pfizer
Phase 3 Completed
NCT07368764 2026-01-28
The Suitability of TienceĀ® for Treating Acne Scars
Linio Biotech Oy
Phase NA Recruiting
NCT04711252 2025-10-14
SERENA-4
AstraZeneca
Phase 3 Active not recruiting
NCT03487549 2024-11-27
COVE-1
Verrica Pharmaceuticals Inc.
Phase 2 Completed
NCT03981822 2024-11-27
CARE-1
Verrica Pharmaceuticals Inc.
Phase 2 Completed
NCT05060237 2024-10-17
Study to Evaluate Safety and Tolerability of BF-200 ALA (AmeluzĀ®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp
Biofrontera Bioscience GmbH
Phase 1 Completed
NCT05636800 2024-08-06
Microwave Treatment for Actinic Keratosis
Blackwell Device Consulting
Phase NA Active not recruiting
NCT05619471 2024-07-25
VISTA
Enspectra Health
Phase NA Completed
NCT05231044 2024-04-19
A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or Scalp
PharmaEssentia
Phase 3 Completed
NCT04177108 2024-03-27
A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer
Hoffmann-La Roche
Phase 3 Completed
NCT06035614 2023-09-13
Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children
Clarteis
Phase NA Completed
NCT03285477 2021-04-13
AK003
Almirall, S.A.
Phase 3 Completed
NCT01763164 2021-03-22
Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
Pfizer
Phase 3 Completed
NCT01490632 2019-09-27
A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis
Eli Lilly and Company
Phase 2 Completed
NCT01743560 2019-07-18
4EVERUK
Novartis
Phase 4 Completed
NCT01831466 2015-11-25
Tofacitinib Ointment For Chronic Plaque Psoriasis
Pfizer
Phase 2 Completed
NCT00753415 2015-03-17
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT00050427 2011-04-28
A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 2 Completed
NCT00894647 2010-08-31
Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery
Graceway Pharmaceuticals, LLC
Phase 3 Completed
NCT00603798 2010-06-29
Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)
Graceway Pharmaceuticals, LLC
Phase 3 Completed
NCT00605176 2010-06-29
Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)
Graceway Pharmaceuticals, LLC
Phase 3 Completed